|
| A) | Medication overuse and unintended dependence | ||
| B) | Medication options for urgent detox | ||
| C) | Medications for opioid use disorder | ||
| D) | Medical operations for unregulated drugs |
| A) | Naloxone, buprenorphine, clonidine | ||
| B) | Methadone, buprenorphine, naltrexone | ||
| C) | Methadone, Narcan, gabapentin | ||
| D) | Suboxone, vivitrol, diazepam |
| A) | The use of a substance only in social situations | ||
| B) | The need for a prescription medication for pain | ||
| C) | The use of a substance regardless of harm and consequences | ||
| D) | The development of a physical reaction when stopping a medication |
| A) | Methadone | ||
| B) | Buprenorphine | ||
| C) | Naloxone | ||
| D) | Naltrexone |
| A) | Full opioid agonist properties | ||
| B) | Low overdose risk because of its ceiling effect | ||
| C) | Only available as daily observed dosing | ||
| D) | Requires hospitalization for administration |
| A) | MOUD doubles the risk of death compared to no treatment. | ||
| B) | MOUD has no effect on mortality risk. | ||
| C) | MOUD significantly reduces mortality risk in OUD. | ||
| D) | MOUD is only effective for reducing mortality during inpatient stays. |
| A) | Methadone | ||
| B) | Buprenorphine | ||
| C) | Naltrexone | ||
| D) | Naloxone |
| A) | Requires withdrawal before initiation | ||
| B) | Can only be given in hospitals | ||
| C) | Requires daily administration | ||
| D) | Causes severe sedation in all patients |
| A) | Gradual onset of withdrawal symptoms over weeks | ||
| B) | Rapid and severe withdrawal caused by antagonists or partial agonists | ||
| C) | A type of withdrawal only seen with methadone | ||
| D) | A withdrawal syndrome caused by stopping MOUD suddenly |
| A) | It reaches a point where increasing the dose gives no greater effect. | ||
| B) | It works best when given at high doses continuously. | ||
| C) | It provides stronger effects the more opioids someone uses. | ||
| D) | It blocks all opioid effects at any dose. |
| A) | Methadone | ||
| B) | Buprenorphine | ||
| C) | Naloxone | ||
| D) | Morphine |
| A) | To increase the euphoria | ||
| B) | To reduce misuse via injection | ||
| C) | To make the medication last longer | ||
| D) | To enhance its analgesic properties |
| A) | Achieve abstinence from all substances within one month | ||
| B) | Detoxify patients in less than 48 hours | ||
| C) | Replace heroin with prescription opioids | ||
| D) | Improve survival and reduce illicit opioid use |
| A) | increases the risk of miscarriage. | ||
| B) | reduces relapse and improves maternal-fetal outcomes. | ||
| C) | reduces birth defects. | ||
| D) | prevents all withdrawal symptoms in newborns. |
| A) | MOUD simply replaces one addiction with another. | ||
| B) | MOUD helps reduce overdose deaths. | ||
| C) | MOUD is an evidence-based treatment. | ||
| D) | MOUD supports long-term recovery. |